Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonner

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
Advances in Radiation Oncology|May 8, 2023
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United StatesAnn C Raldow, Malika L Siker, James A Bonner, et al.
Nature Communications|October 31, 2024
HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cellsHongxing Shen, Oluwagbemiga A Ojo, Haitao Ding, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
International Journal of Oncology|December 20, 2014
Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivityTimothy D Rohrbach, John S Jarboe, Joshua C Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st CenturyWhitney H Beeler, Kent A Griffith, Rochelle D Jones, et al.
International Journal of Oncology|April 4, 2019
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastomaNicholas J Eustace, Joshua C Anderson, Catherine P Langford, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Advances in Radiation Oncology|May 8, 2023
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United StatesAnn C Raldow, Malika L Siker, James A Bonner, et al.
Nature Communications|October 31, 2024
HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cellsHongxing Shen, Oluwagbemiga A Ojo, Haitao Ding, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
International Journal of Oncology|December 20, 2014
Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivityTimothy D Rohrbach, John S Jarboe, Joshua C Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st CenturyWhitney H Beeler, Kent A Griffith, Rochelle D Jones, et al.
International Journal of Oncology|April 4, 2019
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastomaNicholas J Eustace, Joshua C Anderson, Catherine P Langford, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Pageof 32